Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PIK3CA |
Variant | G106_R108del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | PIK3CA G106_R108del results in the deletion of three amino acids in the region linking the PI3K-ABD and PI3K-RBD domains of the Pik3ca protein from amino acids 106 to 108 (UniProt.org). G106_R108del results in increased phosphorylation of Akt and is transforming in cell culture (PMID: 19394761, PMID: 29533785). |
Associated Drug Resistance | |
Category Variants Paths |
PIK3CA mutant PIK3CA act mut PIK3CA G106_R108del |
Transcript | NM_006218.4 |
gDNA | chr3:g.179199142_179199150delGCAACCGTG |
cDNA | c.317_325delGCAACCGTG |
Protein | p.G106_R108delGNR |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_006218.3 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
XM_006713658.5 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
NM_006218 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
XM_011512894 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
NM_006218.4 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
XM_006713658.4 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
XM_006713658 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
XM_011512894.2 | chr3:g.179199142_179199150delGCAACCGTG | c.317_325delGCAACCGTG | p.G106_R108delGNR | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|